Catheter Precision (VTAK) Cash from Financing Activities (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Cash from Financing Activities data on file, last reported at $4.5 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $4.5 million, up 6057.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.9 million (up 13.89% YoY), and the FY2025 annual result was $5.3 million, down 38.19% from the prior year.
• Cash from Financing Activities improved to $4.5 million in Q1 2026 per VTAK's latest filing, from $307000.0 in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $11.2 million in Q1 2022 and troughed at -$516000.0 in Q2 2022.
• A 5-year average of $3.1 million and a median of $2.6 million in 2025 frame the typical range for Cash from Financing Activities.
• On a YoY basis, Cash from Financing Activities climbed as much as 6956.44% in 2022 and fell as far as 104.81% in 2022.
• A 5-year view of Cash from Financing Activities shows it stood at $5.2 million in 2022, then slumped by 102.06% to -$107000.0 in 2023, then soared by 4276.64% to $4.5 million in 2024, then slumped by 93.13% to $307000.0 in 2025, then jumped by 1355.37% to $4.5 million in 2026.
• Business Quant data shows VTAK's Cash from Financing Activities at $4.5 million in Q1 2026, $307000.0 in Q4 2025, and $2.4 million in Q3 2025.